Senzime AB (publ)
SNZZF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.98M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $36.98 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.93 |
| Beta | 0.4 |
| Outstanding Shares | 157,215,046 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -4.11 |
|---|---|
| PEG | 10.88 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
July 16, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$3.19 M
Consensus analyst estimateNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$3.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Senzime AB (publ)
59 employees
CEO: Philip Siberg
Senzime AB (publ) is a medical technology firm specializing in the creation and distribution of advanced patient monitoring solutions. These systems are designed to oversee patients undergoing anesthesia across various global markets, in...